CMS/NCI Collaboration Will Encompass Post-Approval Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
Memorandum of understanding will create a mechanism to identify “high-priority clinical questions.” The collaboration also will examine off-label coverage of cancer drugs and reimbursement for new technologies.